Effectiveness and Safety of Sacubitril/Valsartan in Patients with Chronic Kidney Disease—A Real-World Experience

Effectiveness and Safety of Sacubitril/Valsartan in Patients with Chronic Kidney Disease—A Real-World Experience

Background: data regarding the effectiveness and safety of sacubitril/valsartan in heart failure and reduced ejection fraction (HFrEF) patients with chronic kidney disease (CKD) are scarse. Objective: to evaluate the effectiveness and safety of sacubitril/valsartan in HFrEF and CKD in a real-world p...

Full description

Bibliographic Details
Main Authors: Sara C. Pereira, Tiago Rodrigues, Afonso Nunes-Ferreira, João R. Agostinho, Fausto J. Pinto, Dulce Brito
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Journal of Clinical Medicine
Subjects:
chronic kidney disease
glomerular filtration rate
heart failure with reduced ejection fraction
angiotensin receptor neprilysin inhibitor
sacubitril/valsartan
Online Access:https://www.mdpi.com/2077-0383/12/4/1334

Internet

https://www.mdpi.com/2077-0383/12/4/1334

Similar Items